Patents by Inventor Kyu Kwang Kim

Kyu Kwang Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cross-Linkable Solid Electrolyte Membrane for All-Solid-State Batteries and Method of Manufacturing the Same
    Publication number: 20240145772
    Abstract: An embodiment composition for solid electrolyte membranes of all-solid-state batteries includes a sulfide-based solid electrolyte and a cross-linking agent including two or more acrylate functionalities. An embodiment method of manufacturing a solid electrolyte membrane for an all-solid-state battery includes forming a composition including a sulfide-based solid electrolyte and a cross-linking agent including two or more acrylate functionalities and cross-linking the composition.
    Type: Application
    Filed: September 14, 2023
    Publication date: May 2, 2024
    Inventors: So Yeon Kim, Yun Sung Kim, Ga Hyeon Im, Yoon Kwang Lee, Hong Seok Min, Kyu Joon Lee, Dong Won Kim, Young Jun Lee, Hui Tae Sim, Seung Bo Hong
  • ANODELESS ALL-SOLID-STATE BATTERY INCLUDING COMPOSITE STRUCTURE LAYER AND MANUFACTURING METHOD THEREOF
    Publication number: 20240136499
    Abstract: An anodeless all-solid-state battery includes an anode current collector, a composite structure layer positioned on the anode current collector, a solid electrolyte positioned on the composite structure layer, and a cathode positioned on the solid electrolyte, in which the composite structure layer includes a carbon layer including a carbon material, and a metal deposition layer positioned on the carbon layer and including lithiophilic metal particles.
    Type: Application
    Filed: August 1, 2023
    Publication date: April 25, 2024
    Inventors: GA HYEON IM, Yun Sung Kim, So Yeon Kim, Kyu Joon Lee, Hong Seok Min, Yoon Kwang Lee
  • INHIBITORS OF HUMAN EPIDIDYMUS PROTEIN 4
    Publication number: 20230159586
    Abstract: The present disclosure provides compounds of Formula I for use in the treatment of medical disorders by the inhibition of human epididymal protein 4 (HE4).
    Type: Application
    Filed: April 21, 2021
    Publication date: May 25, 2023
    Inventors: Rakesh Singh, Richard Moore, Kyu Kwang Kim
  • Nitrofuran compounds for the treatment of cancer and angiogenesis
    Patent number: 9220714
    Abstract: The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: December 29, 2015
    Assignees: Brown University, Women and Infants' Hospital Rhode Island
    Inventors: Giselle L. Saulnier Sholler, Narasimha Swamy, Stayan Kalkunte, Rakesh K. Singh, Laurent Brard, Kyu Kwang Kim
  • NITROFURAN COMPOUNDS FOR THE TREATMENT OF CANCER AND ANGIOGENESIS
    Publication number: 20130331383
    Abstract: The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.
    Type: Application
    Filed: May 17, 2013
    Publication date: December 12, 2013
    Applicants: BROWN UNIVERSITY, WOMEN AND INFANTS HOSPITAL OF RHODE ISLAND
    Inventors: Henna Swamy, Laurent Brard, Rakesh K. Singh, Satyan Kalkunte, Narasimha Swamy, Giselle L. Saulnier Sholler, Kyu Kwang Kim
  • Nitrofuran compounds for the treatment of cancer and angiogenesis
    Patent number: 8470815
    Abstract: The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.
    Type: Grant
    Filed: March 7, 2007
    Date of Patent: June 25, 2013
    Assignees: Brown University, Women and Infants' Hospital Rhode Island
    Inventors: Giselle L. Saulnier Sholler, Satyan Kalkunte, Rakesh K. Singh, Laurent Brard, Kyu Kwang Kim, Hena Swamy
  • N-amino tetrahydrothiazine derivatives, method of manufacture and use
    Patent number: 8193180
    Abstract: This invention comprises the innovative synthesis of N-amino tetrahydrothiazine free bases and their salts. This invention further comprises the use of the derivatives and their therapeutic application as anticancer agents. Further this invention comprises their manufacture and use.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: June 5, 2012
    Assignee: Women & Infants Hospital
    Inventors: Laurent Brard, Rakesh Kumar Singh, Kyu Kwang Kim, Giselle Saulnier-Sholler
  • Nitrofuran Compounds for the Treatment of Cancer and Angiogenesis
    Publication number: 20110288080
    Abstract: The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.
    Type: Application
    Filed: March 7, 2007
    Publication date: November 24, 2011
    Inventors: Giselle L Saulnier Sholler, Narasimha Swamy, Henna Swamy, Satyan Kalkunte, Rakesh K. Singh, Laurent Brard, Kyu Kwang Kim